E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/17/2019 in the Prospect News Structured Products Daily.

New Issue: Credit Suisse sells $2.37 million contingent coupon autocallable yield notes on stocks

By Sarah Lizee

Olympia, Wash., April 17 – Credit Suisse AG, London Branch priced $2.37 million of contingent coupon autocallable yield notes due April 18, 2022 linked to the least performing of the shares of CVS Health Corp. and Walgreens Boots Alliance, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a quarterly contingent coupon at an annual rate of 8.75% if each stock closes at or above its coupon barrier, 70% of its initial level, on the observation date.

The notes will be called at par if each stock closes at or above its trigger level, 90% of its initial level, on any quarterly trigger observation date.

The payout at maturity will be par unless any stock finishes below its 70% knock-in level, in which case investors will be fully exposed to any losses of the least-performing stock.

Credit Suisse Securities (USA) LLC is the agent.

Issuer:Credit Suisse AG, London Branch
Issue:Contingent coupon autocallable yield notes
Underlying stocks:CVS Health Corp. and Walgreens Boots Alliance, Inc.
Amount:$2,365,000
Maturity:April 18, 2022
Coupon:8.75% per year, payable quarterly if each stock closes at or above its barrier level on observation date
Price:Par
Payout at maturity:Par unless any stock finishes below knock-in level, in which full exposure to the losses of the least performing stock
Call:Automatically if each stock closes at or above 90% of initial level on any quarterly trigger observation date
Initial prices:$52.81 for CVS, $53.45 for Walgreens
Trigger levels:$47.529 for CVS, $48.105 for Walgreens; 90% of initial prices
Coupon barriers:$36.967 for CVS, $37.415 for Walgreens; 70% of initial prices
Knock-in levels:$36.967 for CVS, $37.415 for Walgreens; 70% of initial prices
Pricing date:April 12
Settlement date:April 17
Agent:Credit Suisse Securities (USA) LLC
Fees:3%
Cusip:22552FAT9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.